{"id": "batch_req_MLvPSMY9BXp4sdFNU4qhd87z", "custom_id": "0_coral_summary_0.0_gpt-4o", "response": {"status_code": 200, "request_id": "793b80e7b0d5c345e47f57e5b45d77a8", "body": {"id": "chatcmpl-9e3o7NcMUHJzOYYor4ZKo5s81jNMW", "object": "chat.completion", "created": 1719334783, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Summary:\n \nAge: 56 years\nGender: Female\nCancer diagnosis: Stage IIA right breast cancer (initial diagnosis in May 2013), now with widely metastatic relapse\nPMH: anxiety, hyperlipidemia\nPrior cancer treatments: right mastectomy with sentinel node and implant reconstruction (June 2013), no radiation or chemotherapy, declined tamoxifen\nCurrent cancer treatments: None (pending biopsy and further treatment planning)\nCurrent medication list: None (patient takes a long list of supplements, details not provided)\nSummary of most recent oncology visit (12/30/2019): 56-year-old female with a history of Stage IIA right breast cancer, now presenting with widely metastatic disease involving lungs, peritoneum, liver, ovary, and local recurrence near the right axilla and implant. Patient reports discomfort and pressure in waist and back, and nausea and burping. CT scan confirmed widespread metastases. Biopsy of right axilla planned to evaluate cancer phenotype. Treatment will be palliative, aiming to improve quality and length of life. Patient is anxious and seeking natural therapies. Referred for MRI of brain, bone scan, and additional labs. Follow-up planned after biopsy results to formulate treatment plan."}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 2291, "completion_tokens": 250, "total_tokens": 2541}, "system_fingerprint": "fp_888385ccad"}}, "error": null}
{"id": "batch_req_ENCHdeUv5ziiYAihFzcH1Xlg", "custom_id": "1_coral_summary_0.0_gpt-4o", "response": {"status_code": 200, "request_id": "2b407e79be6a91d3b3029bc70ca0aa2f", "body": {"id": "chatcmpl-9e3n0GZO0eEy73RWATS0EixOd5tmI", "object": "chat.completion", "created": 1719334714, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Summary:\n \nAge: 44 years  \nGender: Female  \nCancer diagnosis: Early stage endometrial and colon cancer, newly diagnosed metastatic breast cancer  \nPMH: ***** Syndrome, cellulitis, fever and chills, early stage breast cancer (2014), breast cancer local recurrence (2018), DVT, vaginal bleeding, anemia due to malignancy and chemotherapy, peripheral neuropathy, right upper chest pain due to metastases and overlying cellulitis, sacral pain due to metastases, anxiety, chronic headaches, hyponatremia, hypokalemia  \nPrior cancer treatments: Neoadjuvant chemotherapy, partial mastectomy, adjuvant chemotherapy, gemcitabine + carboplatin, Abraxane and Pembrolizumab, irinotecan (started 06/30/19)  \nCurrent cancer treatments: Irinotecan (adjusted to every other week, 150mg/m2 days 1 and 15 every 28 days)  \nCurrent medication list: albuterol, Ambien CR, cyclobenzaprine, diphenoxylate-atropine, docusate sodium, gabapentin, lidocaine-prilocaine, loperamide, lorazepam, lurasidone, magnesium oxide, morphine, omeprazole, ondansetron, oxycodone, polyethylene glycol, pregabalin, prochlorperazine, rivaroxaban, simethicone, naloxone, doxycycline (for chest wall infection), effexor-XR (increased to 75 mg qd), potassium  \nSummary of most recent oncology visit: 44-year-old female with ***** Syndrome, early stage endometrial and colon cancer, and newly diagnosed metastatic breast cancer. She presents for cycle 3 day 1 of irinotecan. She has experienced transaminitis and diarrhea, missing day 8 treatments. She reports increased back pain, chest wall tenderness, erythema, and edema. She has been prescribed doxycycline for possible infection and her irinotecan schedule has been adjusted. She will have scans in 3 months. Anemia is being managed with a unit of pRBC. Hepatitis B monitoring is ongoing. Pain management and other supportive care measures are in place. Follow-up in 2 weeks."}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 5634, "completion_tokens": 466, "total_tokens": 6100}, "system_fingerprint": "fp_3e7d703517"}}, "error": null}
{"id": "batch_req_kIbI3X9nqetpqrvxu1USpYr1", "custom_id": "2_coral_summary_0.0_gpt-4o", "response": {"status_code": 200, "request_id": "1ce1a10fa6989ab62a9c5bc1843502d2", "body": {"id": "chatcmpl-9e3maiHQeAO12EBxpYEIsrF1WhC5P", "object": "chat.completion", "created": 1719334688, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Summary:\n \nAge: 53 years\nGender: Female\nCancer diagnosis: Stage IIA invasive ductal carcinoma (IDC) of the right breast, estrogen receptor positive (ER+), HER2 negative by FISH\nPMH: Hyperlipidemia, pre-diabetes\nPrior cancer treatments: None\nCurrent cancer treatments: None (neoadjuvant therapy recommended)\nCurrent medication list: None\nSummary of most recent oncology visit (08/31/2021): 53-year-old female with mammogram-detected right breast cancer. Tumor size is 1.7 cm with a 1.5 cm positive axillary lymph node. She is HR+, HER2 2+, FISH negative. She has had several opinions and is here for a medical oncology consult. Scheduled for PET CT and genetic testing. Discussed the roles of chemotherapy, surgery, radiation, and hormonal blockade to decrease recurrence risk. Recommended lifestyle modifications including diet, exercise, stress reduction, and sleep management. Follow-up planned after PET and genetic testing results."}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1607, "completion_tokens": 211, "total_tokens": 1818}, "system_fingerprint": "fp_5e6c71d4a8"}}, "error": null}
{"id": "batch_req_TLYs1uK5yrSOXraS4GIMO9Wq", "custom_id": "3_coral_summary_0.0_gpt-4o", "response": {"status_code": 200, "request_id": "12e48eab02ca0cd5e93364c5e957a388", "body": {"id": "chatcmpl-9e3mejihEJLN4uxl5fN7owZKV86xh", "object": "chat.completion", "created": 1719334692, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Summary:\n \nAge: 75 years\nGender: Female\nCancer diagnosis: ER+/PR+/HER2- negative left breast invasive ductal carcinoma\nPMH: Allergic rhinitis, Hepatitis A, Hypercholesterolemia, Hyperlipidemia, Hypertension\nPrior cancer treatments: Left mastectomy with SLN biopsy (10/29/2016)\nCurrent cancer treatments: Letrozole (started 12/02/2016)\nCurrent medication list: Aspirin, Calcium Carbonate, Cholecalciferol (Vitamin D3), Letrozole, Loratadine, Metoprolol Succinate, Metoprolol Tartrate, Pravastatin\nSummary of most recent oncology visit: 75-year-old female with a history of ER+/PR+/HER2- negative left breast invasive ductal carcinoma s/p left mastectomy with SLN biopsy. She is currently on Letrozole and reports no new symptoms since the last visit. Pain in the left upper back, arm, and leg has improved with physical therapy. She experiences occasional muscle cramps, loose stools, and intermittent headaches. No evidence of disease recurrence on imaging, exam, and review of systems. Advised to continue Letrozole, exercises, and supplements. Follow-up in 6 months or sooner if new or worsening symptoms occur."}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 2682, "completion_tokens": 272, "total_tokens": 2954}, "system_fingerprint": "fp_3e7d703517"}}, "error": null}
{"id": "batch_req_ffeu4hQLhDZ06vMtRTW4QFwW", "custom_id": "4_coral_summary_0.0_gpt-4o", "response": {"status_code": 200, "request_id": "954d1c694f260d00e56543cd4f6c07b3", "body": {"id": "chatcmpl-9e3n19XO63mhuyy8CAc4INkyfHsNy", "object": "chat.completion", "created": 1719334715, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Summary:\n \n- **Age:** 31 years\n- **Gender:** Female\n- **Cancer diagnosis:** Recurrent breast cancer, left (Stage III IDC, ER+/PR+/HER2-)\n- **PMH:** Not specified\n- **Prior cancer treatments:** \n  - Bilateral mastectomies (09/08/13)\n  - Dose dense Adriamycin/cytoxan (3 cycles, stopped due to severe side effects)\n  - Anti-estrogen therapy (Lupron, exemestane, tamoxifen)\n- **Current cancer treatments:** \n  - Leuprolide (started January 2019)\n  - Anastrozole (started March 2019)\n  - Palbociclib (started April 2019)\n- **Current medication list:** \n  - Amlodipine\n  - Anastrozole\n  - Escitalopram\n  - Gabapentin\n  - Hydrochlorothiazide\n  - Ondansetron\n  - Palbociclib\n  - Potassium chloride\n  - Venlafaxine\n- **Allergies:** \n  - Gadoterate Meglumine (nausea and vomiting)\n  - Hydrocodone-Acetaminophen\n  - Ibuprofen\n- **Summary of most recent oncology visit (12/07/2019):** \n  - 31-year-old premenopausal female with a history of Stage III IDC of the left breast, now with biopsy-proven metastatic recurrence involving the left cervical lymph nodes. \n  - She is currently on leuprolide, anastrozole, and palbociclib.\n  - She is symptomatic with left brachial plexus involvement and neck pain.\n  - Referred to radiation oncology for symptomatic disease in her left neck and brachial plexus.\n  - Labs to be done monthly on the day of her Lupron injection.\n  - CT and bone scan ordered and pending authorization.\n  - Continues current therapy and will get restaging studies prior to the next visit.\n  - Pain managed with Tylenol; does not want stronger medication.\n  - No significant side effects reported from current therapy.\n  - Performance status: 1 (Symptomatic but completely ambulatory).\n  - Full code status."}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 3331, "completion_tokens": 475, "total_tokens": 3806}, "system_fingerprint": "fp_3e7d703517"}}, "error": null}
{"id": "batch_req_weXUxoSEBUVOWYa1CyLVLZGN", "custom_id": "0_coral_summary_0.7_gpt-4o", "response": {"status_code": 200, "request_id": "d84d0b93ee9a07e1b0b70670309d456e", "body": {"id": "chatcmpl-9e3n1w9erxEMzDrUZx0FoiQxn69yV", "object": "chat.completion", "created": 1719334715, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Summary: \n\nAge: 56 years  \nGender: Female  \nCancer diagnosis: Multifocal Stage IIA right breast cancer, estrogen receptor positive  \nPMH: Anxiety, hyperlipidemia  \nPrior cancer treatments: Right mastectomy with sentinel node and implant reconstruction (June 2013), no radiation or chemotherapy, declined tamoxifen  \nCurrent cancer treatments: None currently  \nCurrent medication list: No current outpatient medications on file.  \nSummary of most recent oncology visit (12/30/2019): 56-year-old female with a history of multifocal Stage IIA right breast cancer presents with widely metastatic cancer to the lungs, peritoneum, liver, and ovary, with local recurrence near the right axilla and implant. The patient reports discomfort and pressure in her waist and back, along with nausea and burping. CT scan reveals widespread metastases. A biopsy of the right axilla is planned to evaluate the phenotype of the cancer. The patient is anxious and is considering natural therapies. Treatment will be palliative, aimed at improving quality and length of life. Will complete staging workup with MRI brain, bone scan, and labs. Appointment scheduled with Dr. ***** for biopsy. Further treatment plan to be formulated after complete workup."}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 2291, "completion_tokens": 252, "total_tokens": 2543}, "system_fingerprint": "fp_3e7d703517"}}, "error": null}
{"id": "batch_req_WawCubXa2j3j1012AvRRkiPx", "custom_id": "1_coral_summary_0.7_gpt-4o", "response": {"status_code": 200, "request_id": "3d907d97a9a76404421cb041484df3a2", "body": {"id": "chatcmpl-9e3moZGMPh6UqT7voZj1sHdOLR5p8", "object": "chat.completion", "created": 1719334702, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Summary:  \nAge: 44 years  \nGender: Female  \nCancer diagnosis: Early stage endometrial and colon cancer, newly diagnosed metastatic breast cancer  \nPMH: ***** Syndrome, cellulitis, fever and chills, vaginal bleeding, DVT (deep venous thrombosis)  \nPrior cancer treatments: Neoadjuvant therapy, partial mastectomy, adjuvant therapy, gemcitabine + carboplatin, Abraxane and Pembrolizumab  \nCurrent cancer treatments: Irinotecan (started 06/30/19, adjusted to 150 mg/m2 days 1 and 15 every 28 days due to poor tolerance)  \nCurrent medication list: albuterol, Ambien CR, cyclobenzaprine (FLEXERIL), diphenoxylate-atropine (LOMOTIL), docusate sodium (COLACE), gabapentin (NEURONTIN), lidocaine-prilocaine (EMLA), loperamide (IMODIUM), LORazepam (ATIVAN), lurasidone (LATUDA), magnesium oxide (MAG-OX), morphine (MS contin), omeprazole (PRILOSEC), ondansetron (ZOFRAN), oxyCODONE (ROXICODONE), polyethylene glycol (MIRALAX), pregabalin, prochlorperazine (COMPAZINE), rivaroxaban (XARELTO), simethicone (MYLICON), venlafaxine (EFFEXOR-XR), naloxone, heparin flush  \nSummary of most recent oncology visit (today): 44-year-old female with ***** Syndrome and early stage endometrial and colon cancer, now presenting with newly diagnosed metastatic breast cancer. She missed her scheduled MRI and chemotherapy appointments due to confusion and transaminitis with diarrhea. She reports persistent chest and back pain, anxiety, depression, and fatigue. The physical exam shows tender, erythematous, and edematous chest wall. Labs indicate anemia, hyponatremia, hypokalemia, and positive hepatitis B core antibody. Plan includes doxycycline for chest wall infection, adjustment of irinotecan dosing, pRBC transfusion, electrolyte management, and follow-up with radiology and oncology for further evaluation and treatment planning."}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 5634, "completion_tokens": 470, "total_tokens": 6104}, "system_fingerprint": "fp_3e7d703517"}}, "error": null}
{"id": "batch_req_zP7LV5jqTpR4ceYiQsLAipr5", "custom_id": "2_coral_summary_0.7_gpt-4o", "response": {"status_code": 200, "request_id": "841b9b3ab4931641726be0dc6dc3d82b", "body": {"id": "chatcmpl-9e3maDVDlel5wNEVSwJlDUNPhPG50", "object": "chat.completion", "created": 1719334688, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Summary:\n \n**Age**: 53 years  \n**Gender**: Female  \n**Cancer diagnosis**: Stage IIA invasive ductal carcinoma (IDC) of the right breast, HR+, Her2-  \n**PMH**: Hyperlipidemia, Pre-diabetes  \n**Prior cancer treatments**: None  \n**Current cancer treatments**: Pending initiation of neoadjuvant therapy  \n**Current medication list**: None listed  \n**Allergies**: No known allergies  \n**Social history**: Never smoker, no alcohol or drug use  \n**Family history**: Father had leukemia, paternal and maternal aunts had breast cancer  \n**Summary of most recent oncology visit (08/31/2021)**: 53-year-old female with newly diagnosed Stage IIA IDC of the right breast. She is scheduled for PET CT and genetic testing. Echo was completed. Discussed the role of chemotherapy, surgery, radiation, and hormonal blockade to decrease recurrence risk. Lifestyle modifications were recommended. Pending follow-up after additional test results.  \n"}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1607, "completion_tokens": 211, "total_tokens": 1818}, "system_fingerprint": "fp_3e7d703517"}}, "error": null}
{"id": "batch_req_torRwD5wCf8RHuqFuERFaSE1", "custom_id": "3_coral_summary_0.7_gpt-4o", "response": {"status_code": 200, "request_id": "50397f50bbc9c560c2ed2ed08cf76c13", "body": {"id": "chatcmpl-9e3mjXLTyFxLow7u9sO1LraDAsIwW", "object": "chat.completion", "created": 1719334697, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Summary:\n Age: 75 years\n Gender: Female\n Cancer diagnosis: ER+/PR+/HER2- left breast invasive ductal carcinoma\n PMH: hypertension, hypercholesterolemia, allergic rhinitis, hepatitis A, osteoporosis, hyperlipidemia\n Prior cancer treatments: left mastectomy with SLN biopsy (10/29/2016)\n Current cancer treatments: letrozole (started 12/02/2016)\n Current medication list: aspirin, calcium carbonate, cholecalciferol (vitamin D3), letrozole, loratadine, metoprolol succinate, metoprolol tartrate, pravastatin\n Summary of most recent oncology visit: 75-year-old female with history of ER+/PR+/HER2- left breast invasive ductal carcinoma, status post left mastectomy and SLN biopsy. Currently on letrozole without evidence of disease recurrence. Reports improved pain in left upper back, left arm, and left leg after physical therapy. Continues to experience occasional muscle cramps, improved with stretching/exercises. Left buttock and anterior thigh pain likely due to osteoarthritis. Osteoporosis is stable, with slight improvement in bone density. Advised to continue calcium and vitamin D supplements and weight-bearing exercises. Chronic headaches and loose stools discussed, with recommendations for follow-up and probiotics respectively. Follow-up in 6 months or sooner if new or worsening symptoms."}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 2682, "completion_tokens": 289, "total_tokens": 2971}, "system_fingerprint": "fp_3e7d703517"}}, "error": null}
{"id": "batch_req_GnZaIfLs53GqGuvxdk9gnN79", "custom_id": "4_coral_summary_0.7_gpt-4o", "response": {"status_code": 200, "request_id": "0eb309e809b5a2166c740d260f233463", "body": {"id": "chatcmpl-9e3mbiCk94Q99jnJklc03CdfOItZM", "object": "chat.completion", "created": 1719334689, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Summary:  \nAge: 31 years  \nGender: Female  \nCancer diagnosis: Recurrent breast cancer, left (HCC), Stage III IDC with ER+/PR+/HER2-  \nPMH: None documented  \nPrior cancer treatments: Bilateral mastectomy (09/08/13), dose-dense Adriamycin/cytoxan (stopped after 3 cycles due to severe side effects), 4-week Lupron, exemestane, later tamoxifen  \nCurrent cancer treatments: Leuprolide (started January 2019), anastrozole (started March 2019), palbociclib (started April 2019)  \nCurrent medication list: amlodipine, anastrozole, escitalopram, gabapentin, hydrochlorothiazide, ondansetron, palbociclib, potassium chloride, venlafaxine  \nSummary of most recent oncology visit (12/07/19): 31-year-old female with a history of Stage III IDC of the left breast (ER+/PR+/HER2-) with biopsy-proven metastatic recurrence. She is currently on leuprolide, anastrozole, and palbociclib. She is experiencing symptoms of left brachial plexus involvement. A referral to radiation oncology has been made for symptomatic disease in her left neck and brachial plexus. She will continue her current therapy and undergo restaging studies. Labs will be done monthly on the day of her Lupron injection. CT and bone scans have been ordered pending authorization."}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 3331, "completion_tokens": 319, "total_tokens": 3650}, "system_fingerprint": "fp_5e6c71d4a8"}}, "error": null}
{"id": "batch_req_qZjSqAmm1GumalRNU68XFzHn", "custom_id": "0_coral_summary_1.0_gpt-4o", "response": {"status_code": 200, "request_id": "6349dcc836646f35c86117d55c6a8e6c", "body": {"id": "chatcmpl-9e3mbb2zDJeiTkkDUWFT1l1R1w4ul", "object": "chat.completion", "created": 1719334689, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Summary:\n Age: 56 years\n Gender: Female\n Cancer diagnosis: Metastatic relapse of Stage IIA right breast cancer with involvement of lungs, peritoneum, liver, ovary and local recurrence near the right axilla and implant. The original cancer was estrogen receptor-positive (ER+), progesterone receptor-positive (PR+), and HER2-negative.\n PMH: Anxiety, hyperlipidemia\n Prior cancer treatments: Mastectomy with sentinel node and implant reconstruction (June 2013), no radiation or chemotherapy, declined tamoxifen.\n Current cancer treatments: None yet, pending tissue confirmation and staging work up\n Current medication list: None reported, long list of supplements to be provided\n Summary of most recent oncology visit (12/30/2019): 56-year-old female with multifocal Stage IIA right breast cancer diagnosed in May 2013. Recent CT scan showed widely metastatic cancer. Biopsy of the right axilla scheduled to confirm phenotype. Discussed palliative treatment options. Will perform MRI brain, bone scan, and labs to complete workup. Planning to see Dr. [Name Redacted] for biopsy and RTC with oncologist for treatment plan formulation. Supportive husband present, patient expressed distress and anxiety."}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 2291, "completion_tokens": 253, "total_tokens": 2544}, "system_fingerprint": "fp_3e7d703517"}}, "error": null}
{"id": "batch_req_JSeWp0n7pceoyFPld81qdvdT", "custom_id": "1_coral_summary_1.0_gpt-4o", "response": {"status_code": 200, "request_id": "17a67825f13688fb9bfcbe13576206e7", "body": {"id": "chatcmpl-9e3nE6AcgQQ0MLbRHRbpmisRpUqVh", "object": "chat.completion", "created": 1719334728, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Summary: \n- **Age:** 44 years \n- **Gender:** Female \n- **Cancer diagnosis:** Early stage endometrial cancer, colon cancer, newly diagnosed metastatic breast cancer, previous breast cancer diagnoses \n- **PMH:** ***** Syndrome, cellulitis, fever and chills, vaginal bleeding, DVT\n- **Prior cancer treatments:** Neoadjuvant chemotherapy, partial mastectomy, adjuvant chemotherapy, gemcitabine + carboplatin, surgery for colon cancer \n- **Current cancer treatments:** Irinotecan (started 06/30/19), modifying irinotecan to 150 mg/m2 every other week \n- **Current medication list:** albuterol, ambien CR, cyclobenzaprine, diphenoxylate-atropine, docusate sodium, gabapentin, lidocaine-prilocaine, loperamide, lorazepam, lurasidone, magnesium oxide, morphine ER, omeprazole, ondansetron, oxycodone, polyethylene glycol, pregabalin, prochlorperazine, rivaroxaban, simethicone, naloxone, doxycycline (new Rx)\n- **Summary of most recent oncology visit (08/11/19):** 44-year-old female with ***** Syndrome, early stage endometrial and colon cancer, now with newly diagnosed metastatic breast cancer. Presents for cycle 3 day 1 of irinotecan but reports worsening back pain potentially due to disease progression. Other significant issues include recurrent cellulitis, anemia, and electrolyte imbalances. Treatment modifications include irinotecan adjustment, antibiotics for cellulitis, and various interventions for symptom management. Recommendations include MRI rescheduling, collaboration with radiation oncology, and continuation or adjustment of current therapies.``"}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 5634, "completion_tokens": 360, "total_tokens": 5994}, "system_fingerprint": "fp_3e7d703517"}}, "error": null}
{"id": "batch_req_u6Fn9B1WEyZaSaKshIjI6Ocx", "custom_id": "2_coral_summary_1.0_gpt-4o", "response": {"status_code": 200, "request_id": "b5e5ad6aa637e276066e1317903446a7", "body": {"id": "chatcmpl-9e3nDe6XNJl1rcmVEZHtwrjr4ECLl", "object": "chat.completion", "created": 1719334727, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Summary:\n Age: 53 years\n Gender: Female\n Cancer diagnosis: Stage IIA IDC (Invasive Ductal Carcinoma) of the right breast, ER+, PR+, HER2 negative by FISH\n PMH: Hyperlipidemia, Pre-diabetes\n Prior cancer treatments: None\n Current cancer treatments: Neoadjuvant chemotherapy recommended, pending PET-CT and genetic testing\n Current medication list: None\n Summary of most recent oncology visit (08/31/2021): 53-year-old female with mammogram-detected right breast cancer (1.7 cm) and positive axillary lymph node (1.5 cm). Patient has had several opinions and is currently scheduled for further evaluation including PET-CT and genetic testing. No significant symptoms reported. Discussed the roles of chemotherapy, surgery, radiation, and hormonal therapy for recurrence risk reduction. Also recommended lifestyle modifications to manage overall health. Patient to follow up after test results are available."}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1607, "completion_tokens": 196, "total_tokens": 1803}, "system_fingerprint": "fp_888385ccad"}}, "error": null}
{"id": "batch_req_Oa9DQ6UwHFgKW1pNidElKwVE", "custom_id": "3_coral_summary_1.0_gpt-4o", "response": {"status_code": 200, "request_id": "21d7f8ee081414f1f621e834e884fb21", "body": {"id": "chatcmpl-9e3qpwWEmqNhRiCc0PvSIFITNavmq", "object": "chat.completion", "created": 1719334951, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Summary:\n- Age: 75 years\n- Gender: Female\n- Cancer diagnosis: ER+/PR+/HER2- left breast invasive ductal carcinoma\n- PMH: allergic rhinitis, hepatitis A, hypertension, hyperlipidemia, osteoporosis\n- Prior cancer treatments: left mastectomy with SLN biopsy (completed 10/29/2016)\n- Current cancer treatments: Letrozole (started 12/02/2016)\n- Current medication list: \n  - Aspirin 81 mg daily\n  - Calcium carbonate twice daily\n  - Cholecalciferol (vitamin D3) 1000 units daily\n  - Letrozole (Femara) 2.5 mg daily\n  - Loratadine 10 mg daily\n  - Metoprolol succinate 50 mg daily\n  - Pravastatin 40 mg nightly\n- Summary of most recent oncology visit: 75-year-old female with a history of ER+/PR+/HER2- left breast invasive ductal carcinoma s/p left mastectomy with SLN biopsy and ongoing adjuvant Letrozole therapy. She reported no new symptoms and overall good wellness. Her leg, upper back, and arm pain improved with physical therapy. She experiences occasional muscle cramps, which improve with stretching, and uses a Chinese herb pain patch as needed for arthritis-related pain. No signs of disease recurrence on imaging, physical examination, or review of systems. Advised to continue Letrozole, keep exercising, and maintain vitamin D and calcium supplementation. Follow-up planned in 6 months or sooner if new symptoms arise."}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 2682, "completion_tokens": 331, "total_tokens": 3013}, "system_fingerprint": "fp_3e7d703517"}}, "error": null}
{"id": "batch_req_sPMqroAVF6b54kkSKhuhx6vi", "custom_id": "4_coral_summary_1.0_gpt-4o", "response": {"status_code": 200, "request_id": "9c1613d5ef2b891ac5592075c71c546d", "body": {"id": "chatcmpl-9e3mb1h5v8EzW6QD0JjU2F4pJUrk3", "object": "chat.completion", "created": 1719334689, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Summary:\n    \n- Age: 31 years\n- Gender: Female\n- Cancer diagnosis: Recurrent breast cancer, left; Stage III IDC (Invasive Ductal Carcinoma), ER+/PR-/HER2-\n- PMH: Not specified, focus on oncologic history\n- Prior cancer treatments: \n  - 2013: Bilateral mastectomies, left axillary surgery, and 3 cycles of dose-dense Adriamycin/Cytoxan\n  - 2013-2015: Lupron and exemestane, later switched to tamoxifen\n  - 2019: Goserelin (started February 2019), Anastrozole (started March 2019), Palbociclib (started April 2019)\n- Current cancer treatments: \n  - Leuprolide (started January 2019)\n  - Anastrozole (started March 2019)\n  - Palbociclib (started April 2019)\n- Current medication list: \n  - Amlodipine\n  - Anastrozole\n  - Escitalopram\n  - Gabapentin\n  - Hydrochlorothiazide\n  - Ondansetron\n  - Palbociclib\n  - Potassium chloride\n  - Venlafaxine\n- Allergies: Gadoterate Meglumine, Hydrocodone-Acetaminophen, Ibuprofen\n- Summary of most recent oncology visit (12/07/2019): \n  - The patient is a 31-year-old premenopausal woman with Stage III ER+/PR-/HER2- IDC of the left breast, with biopsy-proven metastatic recurrence (involving left cervical lymph nodes and brachial plexus).\n  - She is currently on leuprolide, anastrozole, and palbociclib.\n  - MRI of the brain was normal; MRI of the cervical spine showed left brachial plexus involvement.\n  - She is symptomatic and using Tylenol for pain, prefers not to use stronger medications.\n  - She is tolerating therapy well, using Zofran occasionally for nausea.\n  - Labs, including CBC, CMP, Estradiol, Cancer Antigen 15-3, and Carcinoembryonic Antigen, will be obtained during Lupron injection visits.\n  - Imaging studies, including CT of the abdomen/p"}, "logprobs": null, "finish_reason": "length"}], "usage": {"prompt_tokens": 3331, "completion_tokens": 500, "total_tokens": 3831}, "system_fingerprint": "fp_3e7d703517"}}, "error": null}
